These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Metoprolol v. clonidine in the prophylactic treatment of migraine. Louis P, Schoenen J, Hedman C. Cephalalgia; 1985 Sep; 5(3):159-65. PubMed ID: 3899370 [Abstract] [Full Text] [Related]
10. Low-dose clonidine: a review of its therapeutic efficacy in migraine prophylaxis. Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Drugs; 1975 Sep; 10(5-6):357-65. PubMed ID: 1204507 [Abstract] [Full Text] [Related]
15. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo. Zeeberg I, Orholm M, Nielsen JD, Honore PL, Larsen JJ. Acta Neurol Scand; 1981 Dec 19; 64(6):452-9. PubMed ID: 6753446 [Abstract] [Full Text] [Related]
16. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Andersson PG, Petersen EN. Acta Neurol Scand; 1981 Oct 19; 64(4):280-8. PubMed ID: 7032183 [Abstract] [Full Text] [Related]
17. Efficacy of nimodipine in the prophylaxis of migraine. Havanka-Kanniainen H, Hokkanen E, Myllylä VV. Cephalalgia; 1985 Mar 19; 5(1):39-43. PubMed ID: 3886153 [Abstract] [Full Text] [Related]
18. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH, Investigators. Cephalalgia; 2002 Sep 19; 22(7):523-32. PubMed ID: 12230594 [Abstract] [Full Text] [Related]
19. A quantification of the placebo response in migraine prophylaxis. van der Kuy PH, Lohman JJ. Cephalalgia; 2002 May 19; 22(4):265-70. PubMed ID: 12100088 [Abstract] [Full Text] [Related]